At the same time, other studies have reported an association between FOXP1 overexpression and inferior outcome in the context of hematologic malignancies such as follicular lymphoma and diffuse-large B-cell lymphoma (Mottok et al. 2018; Barrans et al. 2004). Here, FOXP1 is linked to hematologic disorder.